Loading...
Haw Par Corporation Limited
HAWPF•PNK
Healthcare
Drug Manufacturers - General
$9.40
$0.00(0.00%)
Haw Par Corporation Limited (HAWPF) Financial Performance & Income Statement Overview
Review Haw Par Corporation Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.50%
↑ 5.50%
Operating Income Growth
-0.26%
↓ 0.26%
Net Income Growth
5.40%
↑ 5.40%
Operating Cash Flow Growth
-14.20%
↓ 14.20%
Operating Margin
28.20%
↑ 28.20%
Gross Margin
57.06%
↑ 57.06%
Net Profit Margin
98.06%
↑ 98.06%
ROE
5.98%
↑ 5.98%
ROIC
1.62%
↑ 1.62%
Haw Par Corporation Limited (HAWPF) Income Statement & Financial Overview
Review Haw Par Corporation Limited's (HAWPF) income statement with detailed quarterly and annual figures.
Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $118.12M | $60.47M | $60.47M | $55.56M |
Cost of Revenue | $53.66M | $24.50M | $24.50M | $24.09M |
Gross Profit | $64.46M | $35.97M | $35.97M | $31.48M |
Gross Profit Ratio | $0.55 | $0.59 | $0.59 | $0.57 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $33.19M | $17.90M | $17.90M | $17.54M |
Operating Expenses | $33.19M | $17.90M | $16.76M | $16.28M |
Total Costs & Expenses | $86.85M | $42.40M | $41.26M | $40.37M |
Interest Income | $0.00 | $14.14M | $39.92M | $11.38M |
Interest Expense | $0.00 | $858000.00 | $0.00 | $697000.00 |
Depreciation & Amortization | $3.05M | $1.45M | $1.45M | $1.47M |
EBITDA | $34.32M | $19.51M | $19.51M | $15.41M |
EBITDA Ratio | $0.29 | $0.32 | $0.32 | $0.28 |
Operating Income | $31.27M | $18.07M | $18.07M | $13.94M |
Operating Income Ratio | $0.26 | $0.30 | $0.30 | $0.25 |
Other Income/Expenses (Net) | $97.88M | $41.06M | $41.06M | $41.63M |
Income Before Tax | $129.15M | $59.13M | $59.13M | $55.57M |
Income Before Tax Ratio | $1.09 | $0.98 | $0.98 | $1.000 |
Income Tax Expense | $7.15M | $2.91M | $2.91M | $3.50M |
Net Income | $122.00M | $56.21M | $56.21M | $52.07M |
Net Income Ratio | $1.03 | $0.93 | $0.93 | $0.94 |
EPS | $0.55 | $0.25 | $0.25 | $0.24 |
Diluted EPS | $0.55 | $0.25 | $0.25 | $0.24 |
Weighted Avg Shares Outstanding | $221.41M | $221.30M | $221.30M | $221.57M |
Weighted Avg Shares Outstanding (Diluted) | $221.41M | $221.16M | $221.16M | $221.57M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan